MYRIAD GENETICS, INC. Increase (Decrease) in Deferred Income Taxes
MYRIAD GENETICS, INC. (MYGN) reported Increase (Decrease) in Deferred Income Taxes of $30.80 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2023-03-01
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2021-12-31 was $4.30M, a 2.38% increase year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2021-09-30 was $16.30M.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2021-06-30 was -$300.00K, a 100.91% decline year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2021-03-31 was $11.80M, a 26.25% decline year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for fiscal 2022 was $30.80M, a 4.05% decline from fiscal 2021.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for fiscal 2021 was $32.10M.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for fiscal 2020 was $55.80M.
- MYRIAD GENETICS, INC. increase (decrease) in deferred income taxes for fiscal 2019 was -$18.60M, a 179.15% decline from fiscal 2018.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 3 month as first filed | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 6 month as first filed | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 9 month as first filed | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $30.80M 10-K · filed 2023-03-01 | |||||||
| 2021-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $20.60M derived: sum of 2 quarters · filed 2023-03-01 | $20.30M derived: sum of 3 quarters · filed 2023-03-01 | $32.10M 10-K · filed 2023-03-01 | ||||
| 2021-09-30 | $16.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $16.00M derived: sum of 2 quarters · filed 2021-11-04 | $27.80M 10-Q · filed 2021-11-04 | $32.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $11.50M 10-Q · filed 2021-08-04 | $15.70M derived: sum of 3 quarters · filed 2023-03-01 | -$32.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $11.80M 10-Q · filed 2021-05-05 | $16.00M derived: sum of 2 quarters · filed 2023-03-01 | -$32.40M derived: sum of 3 quarters · filed 2023-03-01 | $600.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $4.20M derived: 10-K 6 month − 10-Q 3 month · filed 2023-03-01 | -$44.20M 10-K · filed 2023-03-01 | -$11.20M derived: sum of 3 quarters · filed 2023-03-01 | $4.80M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-09-30 | -$48.40M 10-Q · filed 2020-11-09 | -$15.40M derived: sum of 2 quarters · filed 2021-08-04 | $600.00K 10-Q · filed 2021-11-04 | $2.30M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $49.00M 10-Q · filed 2021-08-04 | $50.70M derived: sum of 3 quarters · filed 2021-08-04 | $55.80M 10-K · filed 2023-03-01 | ||||
| 2020-03-31 | $16.00M 10-Q · filed 2021-05-05 | $17.70M derived: sum of 2 quarters · filed 2021-05-05 | $22.90M 10-Q · filed 2020-05-06 | $7.20M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-07 | $6.80M 10-Q · filed 2020-02-07 | -$8.80M derived: sum of 3 quarters · filed 2022-02-25 | -$9.50M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-09-30 | $5.10M 10-Q · filed 2020-11-09 | -$10.50M derived: sum of 2 quarters · filed 2022-02-25 | -$11.20M derived: sum of 3 quarters · filed 2022-02-25 | -$10.80M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-06-30 | -$15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$16.30M derived: sum of 2 quarters · filed 2022-02-25 | -$15.90M derived: sum of 3 quarters · filed 2022-02-25 | -$18.60M 10-K · filed 2022-02-25 | ||||
| 2019-03-31 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-06 | -$300.00K derived: sum of 2 quarters · filed 2020-05-06 | -$3.00M 10-Q · filed 2020-05-06 | -$4.40M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-07 | -$2.30M 10-Q · filed 2020-02-07 | -$3.70M derived: sum of 3 quarters · filed 2021-03-16 | -$4.70M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-09-30 | -$2.70M 10-Q · filed 2019-11-06 | -$4.10M derived: sum of 2 quarters · filed 2021-03-16 | -$5.10M derived: sum of 3 quarters · filed 2021-03-16 | $25.50M derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-06-30 | -$1.40M derived: 10-KT 12 month − 10-Q 9 month · filed 2021-03-16 | -$2.40M derived: sum of 2 quarters · filed 2021-03-16 | $28.20M derived: sum of 3 quarters · filed 2021-03-16 | $23.50M 10-KT · filed 2021-03-16 | ||||
| 2018-03-31 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-08 | $29.60M derived: sum of 2 quarters · filed 2019-05-08 | $24.90M 10-Q · filed 2019-05-08 | $26.10M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-12-31 | $30.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $25.90M 10-Q · filed 2019-02-06 | $27.10M derived: sum of 3 quarters · filed 2019-08-13 | $28.00M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-09-30 | -$4.70M 10-Q · filed 2018-11-07 | -$3.50M derived: sum of 2 quarters · filed 2019-08-13 | -$2.60M derived: sum of 3 quarters · filed 2019-08-13 | -$2.30M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-06-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $2.10M derived: sum of 2 quarters · filed 2019-08-13 | $2.40M derived: sum of 3 quarters · filed 2019-08-13 | -$800.00K 10-K · filed 2019-08-13 | -$1.30M 10-K · filed 2017-08-09 | |||
| 2017-03-31 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $1.20M derived: sum of 2 quarters · filed 2018-05-09 | -$2.00M 10-Q · filed 2018-05-09 | $16.30M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-12-31 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | -$2.90M 10-Q · filed 2018-02-07 | $15.40M derived: sum of 3 quarters · filed 2018-08-24 | $13.70M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-09-30 | -$3.20M 10-Q · filed 2017-11-08 | $15.10M derived: sum of 2 quarters · filed 2018-08-24 | $13.40M derived: sum of 3 quarters · filed 2018-08-24 | -$5.00M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-06-30 | $18.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | $16.60M derived: sum of 2 quarters · filed 2018-08-24 | -$1.80M derived: sum of 3 quarters · filed 2018-08-24 | -$13.20M 10-K · filed 2018-08-24 | -$18.10M 10-K · filed 2016-08-10 | |||
| 2016-03-31 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-03 | -$20.10M derived: sum of 2 quarters · filed 2017-05-03 | -$31.50M 10-Q · filed 2017-05-03 | -$32.10M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-12-31 | -$18.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$29.80M 10-Q · filed 2017-02-08 | -$30.40M derived: sum of 3 quarters · filed 2017-08-09 | -$27.50M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-09-30 | -$11.40M 10-Q · filed 2016-11-02 | -$12.00M derived: sum of 2 quarters · filed 2017-08-09 | -$9.10M derived: sum of 3 quarters · filed 2017-08-09 | -$8.30M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-06-30 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $2.30M derived: sum of 2 quarters · filed 2017-08-09 | $3.10M derived: sum of 3 quarters · filed 2017-08-09 | $400.00K 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-04 | $3.70M derived: sum of 2 quarters · filed 2016-05-04 | $1.00M 10-Q · filed 2016-05-04 | $1.04M 10-Q · filed 2015-05-06 | -$5.27M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-12-31 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-03 | -$1.90M 10-Q · filed 2016-02-03 | -$1.89M 10-Q · filed 2015-02-04 | -$8.17M derived: sum of 3 quarters · filed 2016-08-10 | -$11.83M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-09-30 | -$2.70M 10-Q · filed 2015-11-04 | -$2.69M 10-Q · filed 2014-11-05 | -$8.97M derived: sum of 2 quarters · filed 2016-08-10 | -$12.63M derived: sum of 3 quarters · filed 2016-08-10 | -$11.39M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | -$6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | -$9.93M derived: sum of 2 quarters · filed 2016-08-10 | -$8.69M derived: sum of 3 quarters · filed 2016-08-10 | -$8.10M 10-K · filed 2016-08-10 | -$8.12M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | -$3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | -$2.42M derived: sum of 2 quarters · filed 2015-05-06 | -$1.83M 10-Q · filed 2015-05-06 | -$4.21M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $1.83M 10-Q · filed 2015-02-04 | -$554.00K derived: sum of 3 quarters · filed 2015-08-12 | $325.00K derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | $588.00K 10-Q · filed 2014-11-05 | -$1.79M derived: sum of 2 quarters · filed 2015-08-12 | -$913.00K derived: sum of 3 quarters · filed 2015-08-12 | -$4.59M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | -$1.50M derived: sum of 2 quarters · filed 2015-08-12 | -$5.18M derived: sum of 3 quarters · filed 2015-08-12 | -$7.40M 10-K · filed 2015-08-12 | -$7.47M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $879.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | -$2.80M derived: sum of 2 quarters · filed 2014-05-07 | -$5.02M 10-Q · filed 2014-05-07 | -$4.45M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | -$3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | -$5.90M 10-Q · filed 2014-02-05 | -$5.33M derived: sum of 3 quarters · filed 2014-08-13 | -$8.25M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | -$2.22M 10-Q · filed 2013-11-12 | -$1.65M derived: sum of 2 quarters · filed 2014-08-13 | -$4.58M derived: sum of 3 quarters · filed 2014-08-13 | -$21.06M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | $574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | -$2.35M derived: sum of 2 quarters · filed 2014-08-13 | -$18.84M derived: sum of 3 quarters · filed 2014-08-13 | -$33.63M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | -$19.41M derived: sum of 2 quarters · filed 2013-05-08 | -$34.20M 10-Q · filed 2013-05-08 | |||||
| 2011-12-31 | -$16.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-06 | -$31.27M 10-Q · filed 2013-02-06 | ||||||
| 2011-09-30 | -$14.79M 10-Q · filed 2012-11-09 | |||||||
| 2011-06-30 | -$53.16M 10-K · filed 2013-08-14 | |||||||
| 2010-06-30 | $28.05M 10-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |